L04AX05 · Antineoplastic and immunomodulating agents
Pirfenidone axunio (previously Pirfenidone AET)
Indications
Pirfenidone AET is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).
Composition
- Active substance
- Pirfenidone
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Pirfenidone axunio (previously Pirfenidone AET)
- Active substance
- Pirfenidone
- ATC code
- L04AX05
- Therapeutic area
- Idiopathic Pulmonary Fibrosis
- Marketing authorisation holder
- Axunio Pharma GmbH
- Status
- Authorised
- EU authorisation